Accelerated Age-related Cognitive Decline: Impact of Exercise on Executive Function and Neuroplasticity

Last updated: March 12, 2025
Sponsor: Columbia University
Overall Status: Active - Recruiting

Phase

N/A

Condition

Alzheimer's Disease

Mild Cognitive Impairment

Dementia

Treatment

Home-based walking exercise

Attention control

Clinical Study ID

NCT05655325
AAAU9751
R01AG076456
2022-0311
  • Ages > 55
  • All Genders

Study Summary

The purpose of this study is to see if 6 months of home-based walking will improve memory, and brain structure and function, compared to health education in older adults that have chronic kidney disease and mild cognitive impairment.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • • Diagnosed stage 3-4 chronic kidney disease (CKD, estimated glomerular filtrationrate (eGFR) <60 to 20 ml/min);

  • >55 yrs of age

  • Mild cognitive impairment (18-26 on the MOCA)

  • ability to undergo an MR

  • no history of major head trauma (No head trauma/concussion with loss ofconsciousness)

  • Speaks, reads, writes English

Exclusion

Exclusion Criteria:

  • • Diagnosed Dementia or a Clinical Dementia Rating Scale score of <2, or a MOCA of <18

  • Participating in a supervised exercise program with intent to increase fitnesslevels 3 days/week,

  • Requires assistive ambulation

  • Limited exercise capacity due to claudication; unstable angina, severearthritis, extreme dyspnea on exertion, unstable coronary artery disease

  • Class III-IV heart failure

  • History of uncontrolled sustained arrhythmias, severe/symptomatic aortic ormitral stenosis, hypertrophic obstructive cardiomyopathy, severe pulmonaryhypertension, active myocarditis/pericarditis, thrombophlebitis, and recentsystemic/pulmonary embolus

  • Resting systolic BP >200 mmHg or resting diastolic BP >110 mmHg

  • Any unforeseen illness or disability that would preclude cognitive testing orexercise training

  • One or more contraindication for MRI; cardiac pacemaker, aneurysm clip,cochlear implants, shrapnel, history of metal fragments in eyes,neurostimulators, diagnosed claustrophobia (MRI only)

  • Any self-reported major psychiatric disorders requiring medical therapy (e.g.schizophrenia, bipolar disorder).

  • Self-reported new diagnosis of clinical depression within 3 months ofenrollment or unstable clinical depression requiring medication adjustmentwithin 3 months of enrollment

Study Design

Total Participants: 144
Treatment Group(s): 2
Primary Treatment: Home-based walking exercise
Phase:
Study Start date:
June 18, 2024
Estimated Completion Date:
February 01, 2027

Study Description

Following informed consent, participants will undergo tests for heart health, physical function, memory testing, and brain structure and function using imaging (taking pictures of the brain with an MRI). Following these tests participants are randomized to a home-based walking program or health education for 6 months. Participants are given a fitness tracker and gets ongoing telephone coaching during the 6 months. After 6 months the tests are repeated.

Connect with a study center

  • University of Illinois at Chicago College of Nursing, 2nd floor Clinical Health Research Laboratories. Bronas Laboratory of Vascular and Cognitive Health

    Chicago, Illinois 60612
    United States

    Site Not Available

  • Columbia University

    New York, New York 10023
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.